SLAS2026 NexusXp: The Connected Lab

Only available as part of a package

After last year’s successful debut, the NexusXp pavilion returns to SLAS2026, with an even sharper focus on integrative automation, seamlessly connecting devices, platforms and people to advance scientific workflows. Designed to spark collaboration between vendors and researchers, NexusXp highlights real-world lab automation scenarios that blend hardware, software and human ingenuity.

Recorded sessions include:

  • Engaging panel discussions
  • Poster Lightning Talks
  • Flash talks


Key:

Complete
Failed
Available
Locked
Integration Showcase Panel Discussions
From R&D to Regulated: Best practices strategy in implementing and governing end-to-end Clinical Laboratory Automation
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Automation has traditionally been rooted in R&D, but increasing demands and growing expectations for speed, reproducibility, and compliance are driving its adoption in regulated (GxP) environments. This shift introduces challenges—such as aligning flexible research workflows with strict regulatory requirements—but also creates unprecedented opportunities for technology innovation that can help biopharma accelerate strategic decision-making in drug and vaccine development. In this session, leaders from Moderna and Thermo Fisher Scientific will share practical strategies for planning, implementing, and validating automated systems in regulated clinical testing settings. The discussion will highlight best practices from initial design through regulatory engagement, providing attendees with a clear roadmap for successfully investing in, deploying, and scaling lab automation.
You must register to access.
The Road to Self-Driving Labs: Where We Are and What Comes Next
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Autonomous laboratories are no longer a distant vision— they are redefining competitive advantage in the life sciences R&D. In this session, Ginkgo Bioworks co‑founder and CEO Jason Kelly will share an insider’s view of how leading organizations are deploying automation today, introducing a clear framework for levels of laboratory autonomy (LoLA) that spans from basic task automation to systems that can design, run, and optimize experiments with minimal human oversight. Anchored in real programs from Ginkgo and across the broader ecosystem, the talk will highlight what’s unlocking step‑change gains in speed, cost, and reproducibility, where adoption is accelerating fastest, and what strategic, technical, and organizational hurdles innovators must navigate to win in the era of fully autonomous labs. Jason will also be joined by Nick Edwards, CEO of Potato AI that is building AI scientists for closed-loop optimization of experiments. https://www.potato.ai/
You must register to access.
Designing the Future: Collaborative Innovation in DMTA
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available In the DMTA cycle, the DESIGN phase sets the foundation for innovation. As experimental complexity grows, flexible and interoperable design solutions are critical to accelerating discovery. Hamilton Robotics, a leader in precise automated liquid handling, is advancing beyond hardware by fostering collaborations that bridge physical automation with cutting-edge experimental workflow design software. This panel discussion session will explore how integrated approaches—combining Hamilton’s liquid handling expertise with partner-driven design tools—can unlock smarter workflows and enable closed-loop science. Join Hamilton and leading voices in lab automation to discuss strategies for creating adaptable, data-driven design ecosystems that empower scientists and shape future drug discoveries.
You must register to access.
Bridging Discovery, Imaging, and the Future
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Join a distinguished panel of SLAS leadership — including Past Presidents and Board Directors— Tim Spicer, Philip Gribbon, and Zack Guard-Levin and Glauco Souza for a strategic dialogue on the future of drug discovery. This session explores the convergence of biochemical screening, phenotypic screening, 3D biology, advanced imaging, AI, and laboratory automation. Panelists will share their vision for how bridging these technologies reshapes discovery workflows and accelerates the path from target to therapeutic.
You must register to access.
Poster Lightning Talks
High Throughput Pipeline for Creation and Characterization of Genetic Variants
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.
Cell2Read: An Automated Workflow to Generate Sequencing-Ready DNA Libraries from Human Cell Suspensions
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.
Open-Source Interoperable Framework for Rapid Workflow Design in Laboratory Automation
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.
Automating the Un-Automatable: Acoustic Liquid Handling Without the Glue
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.
Multi-scale high throughput stack screening of zebrafish larvae using a Multi-Camera Array Microscope in 96 well plates
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.
Flash Talks
How 3D Biology Becomes the Engine of the Future
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Three-dimensional cell culture is one of the fastest growing segments in life sciences, driven by FDA modernization and the adoption of New Approach Methodologies (NAMs). This session examines how 3D biology is transitioning from early adoption to scalable discovery platform. We'll explore enabling technologies—including magnetic 3D cell culture—for automation and reproducibility, and introduce new spheroid plate innovations designed for optimal imaging and consistent spheroid formation. Practical considerations for integration into existing HTS workflows will be discussed.
You must register to access.
Better Plates, Better Data: Why plates make a difference in HCS
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available High‑content screening (HCS) relies on high‑resolution imaging and robust, reproducible data. Beyond optics and software, microplate design and surface properties are key determinants of imaging performance and biological relevance. This session highlights critical microplate features for high‑resolution microscopy, including optical performance, bottom thickness uniformity, plate geometry, and surface properties, and explains how these parameters affect image quality and data reliability. By comparing solutions for different HCS requirements, it demonstrates how selecting the right plate enables more reliable imaging and better data.
You must register to access.